| Q35724582 | A study of HDV in HBsAg positive patients in Tabriz, Northwestern Iran. |
| Q35171720 | Advances in the diagnosis and management of human viral hepatitis |
| Q40322072 | Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982-2003). |
| Q43047852 | Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection |
| Q49216574 | Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies |
| Q57097288 | Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study |
| Q45409040 | Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon |
| Q45758534 | Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors |
| Q45758536 | Decreasing prevalence of hepatitis D virus infection |
| Q34045260 | Delta hepatitis-related thyroid disease: a unique phenomenon |
| Q34288172 | Delta hepatitis: an update |
| Q39730646 | Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan |
| Q33801300 | Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy |
| Q44071065 | Famciclovir treatment of chronic delta hepatitis |
| Q34737096 | Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination |
| Q34024141 | Hepatitis D virus: an update |
| Q33629416 | Hepatitis D: Scenario in the Asia-Pacific region |
| Q39494133 | Hepatitis delta infection in Italian patients: towards the end of the story? |
| Q83927727 | Hepatitis delta virus |
| Q26783367 | Hepatitis delta virus: Making the point from virus isolation up to 2014 |
| Q33875709 | Hepatitis delta virus: the molecular basis of laboratory diagnosis |
| Q35886670 | Impact of comorbidities on the severity of chronic hepatitis B at presentation |
| Q40778961 | Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice |
| Q39419887 | Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study |
| Q37781102 | Natural history and treatment of chronic delta hepatitis |
| Q45375325 | Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider |
| Q45370117 | Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. |
| Q39431097 | Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India |
| Q44854130 | The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? |
| Q42721552 | Unthought-of problems regarding hepatitis D virus infection |
| Q73636639 | Update on hepatitis B vaccination in Italy 10 years after its implementation |